This investigation evaluated the effect of probenecid on ceforanide concentrations in eight healthy volunteers. Each volunteer was given 1 or 2 g of ceforanide either alone or with 1 g of probenecid. Concentrations of ceforanide in plasma, urine, and saliva were then measured. Probenecid did not alter the plasma concentrations of ceforanide, nor did it affect the urinary excretion of this agent. Ceforanide was not secreted into saliva in any detectable amount either when administered alone or with probenecid. It is not clear why probenecid has a negligible effect on ceforanide concentrations in plasma. It may be that tubular secretion plays less of a role in the excretion of ceforanide than expected, or that the physical properties of ceforanide prevent probenecid from affecting its excretion.
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Probenecid has been shown to alter the p)harmacokinetics of the penicillin and cephalosporin compounds (3) (4) (5) (6) 9) , mainly through competitive inhibition of the secretion of these antimicrobial agents within the renal tubules. Based on this principle ceforanide, a new, long-acting, semisynthetic cephalosporin, has been used with probenecid to treat life-threatening infectious diseases (2). We undertook this investigation to determine the effects of probenecid on plasma, urinary, and salivary concentrations of ceforanide. Since earlier investigations have suggested that ceforanide is excreted bv glomerular filtration and tubular secretion, one would expect that probenecid would increase levels of ceforanide in plasma, as it has the levels of other cephalosporins (7 Probenecid. Commercially available 50()-nmg tablets of probenecid were tItilized(. Investigation. Each of the subjects was randonlyv assigned to receive either 1 g of ceforanide intramiuscularlv and 2 weeks later 2 g of' ceforanide intramuscularlv with probenecid taken orally or 2 g of ceforanide intramusularly alone and 2 weeks later I g of ceforanide intramuscularlY with probenecid taken orally. In all cases ceforanide and probenecid were adnministered simultaneously. Four subjects were assigned to each dosing reginmeni.
Plassma samples f'or ceforani(le concentrations were obtained immediately before administrationi of the drug, at 3}0 min, and at 1, 2, .3, 5, 9, 12, and 24 h after the injection. Specimens of saliva were obtained each time a blood specimen was dlrawn. We obtained 3 ml of saliva for each sample. I'roduction of' saliva was stimulated by having each subject chew on paraffin wax. All urine during the f'ollowing time intervals was collected for determination of ceforanide concentrations: 0 to 4, 4 to 6, and 6 to 12 h after adnministration of 1 g of ceforanide, and at 0 to 2, 2 to 4, 4 to 6, and 6 to 12 h after the administration of 2 g of ceforanide.
Antibiotic Concentrations of ceforanide in saliva were less than 0.5 tig/ml, whether ceforanide was administered alone or with probenecid. Table 2 shows the maximal concentrations, the times at which they occurred, and the halflife of ceforanide for each regimen. The area under each of the curves in Fig. 1 Data from our study also indicate that ceforanide is not secreted into saliva in any significant amount even when administered with probenecid. This may be significant since it has been shown that cephalosporins do not affect the meningococcal carrier state or eradicate oral gonococcal infections because of poor salivary concentrations (8) .
